HERON THERAPEUTICS INC
HRTX·427746102·US·Common Stock·Healthcare - Biotechnology-Activist
HRTX (HERON THERAPEUTICS INC) is held by 86 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($8.1M), VANGUARD CAPITAL MANAGEMENT LLC ($6.2M), MILLENNIUM MANAGEMENT LLC ($6.1M). Net institutional sentiment: Mixed.
86
Holders
Avg rating(25 Elite)
$46.5M
Total Value
52% (96)
Fund Consensus
46 buying - 42 selling
Who's Trading
ActivistADAdage Capital Management, L.P.0.0%May 13, 2026
InsiderHEHensley Mark EarlExercise 125K shMay 6, 2026
InsiderCACollard Craig AExercise 50K shApr 30, 2026
InsiderCACollard Craig AExercise 35K shApr 30, 2026
InsiderDIDuarte IraExercise 14K shApr 30, 2026
InsiderDIDuarte IraExercise 12K shApr 30, 2026
InsiderFPForbes William PExercise 12K shApr 30, 2026
InsiderFPForbes William PExercise 12K shApr 30, 2026
InsiderHEHensley Mark EarlExercise 12K shApr 30, 2026
13F: Insider & Congress:
Showing 1-20 of 96
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer